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ABSTRACT
The tRNA
Lys anticodon nuclease PrrC is associated
in latent form with the type Ic DNA restriction
endonuclease EcoprrI and activated by a phage
T4-encoded inhibitor of EcoprrI. The activation also
requires the hydrolysis of GTP and presence of
dTTP and is inhibited by ATP. The N-proximal
NTPase domain of PrrC has been implicated in
relaying the activating signal to a C-proximal anti-
codon nuclease site by interacting with the requisite
nucleotide cofactors [Amitsur et al. (2003) Mol.
Microbiol., 50, 129–143]. Means described here to
bypass PrrC’s self-limiting translation and thermal
instability allowed purifying an active mutant form
of the protein, demonstrating its oligomeric struc-
ture and confirming its anticipated interactions with
the nucleotide cofactors of the activation reaction.
Mutagenesis and chemical rescue data shown impli-
cate the C-proximal Arg
320, Glu
324 and, possibly,
His
356 in anticodon nuclease catalysis. This triad
exists in all the known PrrC homologs but only
some of them feature residues needed for tRNA
Lys
recognition by the Escherichia coli prototype. The
differential conservation and consistent genetic
linkage of the PrrC proteins with EcoprrI homologs
portray them as a family of restriction RNases of
diverse substrate specificities that are mobilized
when an associated DNA restriction nuclease is
compromised.
INTRODUCTION
Bacteria activate suicide programs in dire situations (1)
including phage infection (2). A case in point is the tRNA
Lys
anticodon nuclease (ACNase) PrrC (3–6) encoded by the
optional Escherichia coli prr locus (7). ACNase activity is
silenced by physical association of PrrC with the genetically
linked type Ic DNA restriction endonuclease EcoprrI (8–11).
A phage T4-encoded peptide inhibitor of EcoprrI termed Stp
activates the latent ACNase, possibly by altering the PrrC-
EcoprrI interaction (10,12–18). The resultant transesterifying
cleavage of tRNA
Lys (4) could block T4 late translation and
contain the infection (19) but the T4-coded 30-phosphatase/
50-polynucleotide kinase (Pnk) and RNA ligase1 (Rli1)
normally offset the damage (4,20). PrrC homologs appear
sporadically among distantly related bacteria always linked
to EcoprrI homologs (17,18) (Figure 1).
High level expression of PrrC elicits overt (core) ACNase
activity in E.coli (8,21) or cultured human cells (22) but self-
limiting translation and thermal instability have impeded the
isolation of the core ACNase protein in active form (21,23).
Notions about the functional organization of PrrC have been
inferred from sequence comparisons, mutagenesis and func-
tional assays performed in vivo or with crude fractions.
These data suggest that PrrC’s N-proximal 2/3 harbors an
ABC transporter-likeNTPase(Figure1)thatmediates theacti-
vation of ACNase by hydrolyzing GTP. Another co-activating
nucleotide is dTTP that seems to cooperate with GTP without
being hydrolyzed and effectively protects the core ACNase
activity of free PrrC. ATP is yet another, negative effector of
ACNase reaction. However, it has been uncertain whether all
three nucleotides exert their effects through PrrC (18).
PrrC’s remaining part contains residues involved in
tRNA
Lys recognition (23–25). The main cues recognized in
tRNA
Lys by PrrC are in the anticodon stem–loop region and
comprise the anticodon bases, base modiﬁcations and base-
pairing interactions (22–25). The transesterifying cleavage
of tRNA
Lys catalyzed by PrrC resembles the ﬁrst step in ‘clas-
sical’ RNase reactions (26,27) where an entering 20-oxygen
displaces a leaving 50 group at the phosphorous atom in a
concerted in-line mechanism involving a pentameric transi-
tion state phosphate (TSP). The classical RNases employ
Glu or His as the general base, His as a general acid and
Arg or Lys to neutralize the negative charge that develops
on the TSP (28). Each of the three catalytic groups could
provide upto 10
4-fold rate enhancement (29). Whether PrrC
contains a similar catalytic triad has been unknown.
Means described here to bypass PrrC’s self-limiting
translation and thermal instability enabled (i) the isolation
of an active mutant form of the core ACNase protein,
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doi:10.1093/nar/gkl415(ii) demonstrating its oligomeric, possibly tetrameric struc-
ture and (iii) conﬁrming the anticipated interactions of PrrC
with the nucleotides implicated in ACNase latency and
activation. Other data suggest that the conserved Glu
324,
Arg
320 and, possibly, His
356 partake in ACNase catalysis.
This triad is conserved by all known PrrC homologs unlike
the residues needed for tRNA
Lys recognition, suggesting
that the PrrC proteins constitute a family of restriction
RNases that vary in substrate speciﬁcity.
MATERIALS AND METHODS
Materials
The gel ﬁltration calibration kit of native proteins was pur-
chased from Pharmacia Biotech. Pre-stained Broad-Range
and SeeBlue Plus 2 markers for calibrating polypeptide size
in SDS–PAGE were purchased from New England Biolabs
or Invitrogen, respectively, TALON  immobilized-metal
afﬁnity resin from Clontech. The sources of other materials
have been described (18,23,25).
PrrC mutants
The D222E mutant has been described (23). Missense
mutants generated in this work were obtained by the Quick
Change method (30). The His6-tag was fused to PrrC’s
C-end by introducing ﬁrst an Age I site that entailed an
Asn
394!Thr replacement. This site served to insert a DNA
fragment encoding a ﬂexible linker, factor Xa site and His6
[G3S(G4S)2IEGRGSH6]. The resultant fusion protein retained
the parental ACNase activity and stability.
PrrC-expression plasmids and bacterial hosts
The PrrC proteins were expressed under the control of the
T7-Lac promoter and Shine–Dalgarno sequence of plasmid
Figure 1. Domain organization and sequence conservation of E.coli PrrC. The degree of conservation across the sequence of E.coli PrrC was processed and
color-coded by ConSeq (Pupko et al. 2002; http://conseq.bioinfo.tau.ac.il) based on a ClustalW alignment (45) of the query sequence with sequences of
19 homologs. These homologs are encoded by the following bacteria and indicated by the respective accession numbers and three letter abbreviations:
Acidothiobacillus ferrooxidans (Afe), nl|TIGR_920|contig:10033:a_ferrooxidans; Actinobacillus pleuropneumoniae (Apl), gnl|OUACGT_
44294|ap5.fasta.screen.Contig198; Azoarcus sp. EbN1 (Azo), NC_006513.1; Brevibacterium linens BL2 H (Bli), NZ_AAGP01000001.1|; Burkholderia
pseudomallei 1655 (Bup), NZ_AAHR01000011.1; Haemophilus influenzae R2846 (Hin), ZP_00154666.1; Leptospira interrogans serovar Copenhageni str.(Lin),
YP_000904.1; Magnetococcus sp. MC-1 (Mag), ZP_00289847.1: Methylobacillus flagellatus KT (Mfl), ZP_00201874.1;Neisseria meningitidis MC58 (Nme),
NP_273873.1; Photorhabdus luminescens subsp. laumondii TTO1 (Plu), NP_931496.1; Prosthecochloris aestuarii DSM 271 (Pae), EAN22302.1;
Rhodopseudomonas palustris HaA2 (Rhp), NZ_AALQ01000003.1; Shewanella baltica OS155 (Sba), AAIO01000005.1; Streptococcus equi (Seq),
gnl|Sanger_1336| Contig227; Streptococcus mutans (Smu), NC_004350.1; Vibrio vulnificus YJ016 (Vvu), NP_933608.1; Xanthomonas campestris (Xca),
NC_003902.1. Yersinia frederiksenii ATCC 33641 (Yfr), ZP_00829622.1; Motifs and functional sites indicated over the sequence include those typical of ABC
transporter ATPases (41) including the Walker A and B motifs, the ABC signature motif and the switch region or linchpin His (37); the 284–294 stretch
implicated in recognition of the tRNA
Lys anticodon (23–25) and the putative ACNase catalytic triad Arg
320, Glu
324 and His
356 (this work). Conservation scale:
-Insufficient data—the calculation for this site was performed on <10% of the sequences.
3210 Nucleic Acids Research, 2006, Vol. 34, No. 11pRRC11 (23) in E.coli Rosetta (DE3)pLysS encoding rare
tRNAs from plasmid pRARE (Novagen, UK) (31). The iso-
genic BL21:pLysS strain lacking pRARE was a control.
PrrC protein was monitored by immunoblotting using puriﬁed
polyclonal anti-PrrC antibodies (23).
ACNase assays
In vivo core ACNase activity was assayed by 50 end-labeling
the cleavage termini generated by ACNase using [g-
32P]ATP
and T4 Pnk, as described previously (18,23,24). Brieﬂy, the
labeling was performed on total low weight RNA extracted
from cells induced to express the indicated form of PrrC
and the products separated by denaturing gel electrophoresis
along with controls from cells not expressing PrrC. The iden-
tity of the product has been ascertained by their migration
with tRNALys fragment 34–76, hybridization to complemen-
tary DNA probes and 50 end-group analysis (18,23,24). The
detection limit of this assay was estimated by serial dilutions
of the RNA from the PrrC-expressing cells with RNA from
isogenic, non-expressing cells. PrrC induction was limited
to 30–45 min, during which ACNase products continue to
accumulate also with wild-type PrrC. In the in vitro ACNase
assays puriﬁed E.coli tRNA
Lys labeled with
32P at the 33p34
cleavage junction was used as substrate (16). The standard
reaction mixtures (10 ml) contained the indicated amount
of PrrC [diluted where needed in buffer VI (detailed below)
containing 1 mg/ml BSA], 1 fmol of the
32P-labeled substrate
(3000 Ci/mmol), 2 mM dTTP, 5 mM Na-HEPES buffer
(pH 7.5); 0.5 mM MgCl2, 15 mM NaCl, 5% glycerol
and typically 0.25–0.5 M trimethylamine-N-oxide (TMAO).
The reaction was performed at 10 C and terminated by
adding 1.5 vol of 10 M urea, 0.01% bromphenol blue and
0.01% xylene cyanol. The products were separated by
polyacrylamide–urea gel electrophoresis (18).
Bacterial growth and isolation of PrrC
E.coli Rosetta (DE3)pLysS transformants encoding the var-
ious PrrC forms were grown to  0.5 OD600 at 37 Ci n
Luria–Bertani (LB) medium containing 100 mg/ml ampicilin
and 34 mg/ml chloramphenicol. A total of 1 mM isopropyl-b-
D-thiogalactopyranoside (IPTG) was added to induce expres-
sion. The culture was shifted to 30 C and incubated for 2 h.
All subsequent steps were at 0–4 C. The cells were harvested
by centrifugation and the pellet washed twice in buffer I
[10 mM Tris–HCl (pH 7.5); 15 mM MgCl2, 1 M KCl and
10% glycerol], once in buffer II (Buffer I with 50 mM
KCl) and then suspended at 1:1.5 w/v in buffer III [10 mM
Na-HEPES (pH 7.5); 1 mM MgCl2, 30 mM NaCl, Protease
inhibitor cocktail tablet, EDTA-free (Roche); and 10% gly-
cerol]. The cells were disrupted in an Amicon pressure cell
at 18 000 psi and the lysate made upto 1–2 M TMAO and
centrifuged for 30 min at 30000 g in a Sorvall SS-34 rotor.
The supernatant containing  30 mg/ml protein was supple-
mented with 2–10 mM dTTP and 5 mM imidazole and loaded
at a 4:1 v/v ratio on a TALON column equilibrated with buf-
fer IV (buffer III containing 10 mM dTTP, 5 mM imidazole
and 2 M TMAO). The column was washed with 10 vol of
the same buffer and the bound protein eluted with buffer V
(buffer IV with 0.5 M imidazole). The eluted fraction was
desalted by passage through a 2 ml Sephadex G-50 column
equilibrated with buffer VI (buffer III containing 2 mM
dTTP, 1 M TMAO), loaded onto a 30 ml Superdex-200
XK16 gel ﬁltration column (Pharmacia, separation range:
10
4   6 · 10
5 Da) equilibrated with buffer VI and fractio-
nated in the Biologic HR chromatography system (Bio-Rad)
at a ﬂow rate of 0.25 ml/min. PrrC protein was monitored
throughout the puriﬁcation by protein staining, immunoblot-
ting and core ACNase assay. The identity and purity of the
PrrC protein band was ascertained by mass spectrometry.
Glutaraldehyde protein–protein crosslinking
The reaction was initiated by adding 0.01% glutaraldehyde to
the indicated PrrC fraction kept at 0 C and terminated at the
indicated time by adjusting the mixture to 0.1 M Tris–HCl
buffer (pH 7.5). Samples were mixed with gel loading buffer,
heated for 5 min at 100 C and separated on 10% or 5–13%
gradient SDS–PAGE. The products were detected by staining
with SeeBand Forte (GeBa) or immunoblotting.
UV-crosslinking nucleotides to PrrC
The UV-crosslinking mixture (10 ml) contained PrrC (post-
TALON fraction in buffer III containing 1 M TMAO) at
50 ng with dTTP, 500 ng with GTP or ATP and the indicated
concentrations of one of the following radio-labeled nucleo-
tides: 0.2–5 mM[ a-
32P]dTTP (300Ci/mmol) or 0.1–1.5 mM
[a-
32P]GTP or ATP (1 Ci/mmol). The samples were placed
in Cell-cut 60-well plates and irradiated from above at a
distance of 10 cm for 5 min with a UV254 lamp (UVGL-25,
San Gabriel). The photolabeled product and total PrrC
were separated by SDS–PAGE, transferred to a nitrocellu-
lose membrane and visualized by autoradiography and
immunoblotting.
Chemical rescue
Chemical rescue was measured by adding varying concentra-
tions of guanidine, acetate, imidazole or phenol to ACNase
reaction mixtures containing the indicated PrrC alleles. In
calculating the rate enhancement nonspeciﬁc effects of the
rescuing agent on the wild-type control were considered.
RESULTS
Isolation of the active oligomeric form of a PrrC mutant
Expression of PrrC inactivates essential tRNAs and inhibits
translation, including PrrC’s. However, PrrC mutants
impaired in ACNase activity accumulate to higher levels,
inversely proportional to the residual activity (23). This
observation suggested that leaky PrrC mutants would facili-
tate the isolation of active core ACNase forms. One of
them, PrrC-D222E, was chosen for further work due to its
relatively high in vitro stability. Cells expressing PrrC-
D222E featured lower in vivo ACNase activity than wild-
type PrrC (23) (Figure 2A). Yet, the cell-free extract of the
PrrC-D222E mutant was as active as the wild-type counter-
part (Figure 2B). This difference was due to the higher
in vitro stability of the mutant activity and, in turn, the higher
level of the mutant protein. Namely, in the original cell
extract the mutant activity decayed slower than the wild-
type but similar decay rates were observed when the
Nucleic Acids Research, 2006, Vol. 34, No. 11 3211concentrations of the two PrrC forms in the cell extract were
equalized (Figure 2C). The PrrC protein yield could be
further increased by expression in the Rosetta strain
(Figure 2D), thus compensating for the abundant rare codons
in prrC. However, co-expressing T4 Pnk and Rli1 to counter-
act ACNase cleavage increased the yield of wild-type PrrC
only (data not shown). Thus, the relatively weak activity of
PrrC-D222E did not limit its translation.
ACNase activity could be further stabilized by the chemi-
cal chaperone TMAO that folds back denatured proteins
and restores their enzymatic activities (32). This was shown
by pre-incubating PrrC-D222E samples at 15–40 C with
Figure 2. Protein levels and ACNase activities of wild-type and D222E alleles of PrrC. (A) In vivo levels of protein and ACNase cleavage products of the two
PrrC forms. The expression of the two forms was induced by IPTG and the cellular levels of their protein and ACNase cleavage products were then determined as
detailed in Materials and Methods. (B) In vitro ACNase activity of the indicated PrrC forms was determined as detailed in Materials and Methods. (C) Decay
rates of the in vitro ACNase activity of wild-type and D222E forms of PrrC. The PrrC-D222E fraction was assayed as such or diluted 20-fold in an isogenic
extract lacking PrrC. The dilution equalized the protein levels of the mutant and wild-type forms. Aliquots were pre-incubated at 37 C in the presence of 2 M
TMAO and assayed for remaining ACNase activity at 10 C and 0.5 M TMAO under standard assay conditions. D222E 1:20 indicates D222E diluted 20-fold.
(D) Levels of PrrC-D222E protein in the indicated E.coli strains.
3212 Nucleic Acids Research, 2006, Vol. 34, No. 110–2 M TMAO followed by assaying the remaining ACNase
activity at 10 C and 1 M TMAO. The data indicated that
the Tm of ACNase inactivation could increase upto  10 C
at 2 M TMAO (Figure 3). However, the presence of TMAO
in the reaction mixture did not restore the activity once lost.
Core ACNase is stabilized also by dTTP (18), an effect
added to that conferred by TMAO (data not shown).
Therefore, both compounds were included in the enzyme
fractions and column buffers during attempted puriﬁcation
of the core ACNase protein. These measures enabled purify-
ing an active PrrC-D222E derivative containing a C-terminal
His6-tag (Materials and Methods) through immobilized-metal
afﬁnity-chromatography and gel ﬁltration (Figure 4A and B;
Table 1). Wild-type PrrC was puriﬁed similarly but was
rapidly inactivated (data not shown). For convenience, the
His6 derivative of PrrC-D222E is referred to below mostly
as PrrC.
ACNase activity and PrrC protein eluted from the gel
ﬁltration column in peaks that almost completely overlapped
and corresponded in position to a globular protein of
 200 kDa (Figure 4B). This suggested that the activity
resides in a PrrC oligomer. Since the thermal inactivation
of ACNase occurs without dissociation of the PrrC oligomer
(Figure 5B), the subtle differences between the positions of
PrrC and ACNase peaks could reﬂect the different shapes
of active and inactive PrrC forms rather than size heterogene-
ity. Glutaraldehyde protein–protein crosslinking performed
on the post-TALON or the gel ﬁltration fractions yielded
three groups of product bands migrating in SDS–PAGE
slower than the PrrC monomer (shown in Figure 4C for the
post-TALON fraction). Judged from the position of these
products relative to the size markers they were considered
as different crosslinking versions of dimer, trimer and tetra-
mer forms. Such a pattern with a relatively low level of
trimer bands has been observed with known dimer of dimers
proteins, including an ABC transporter ATPase (33–36).
Figure 4. Isolation of PrrC and determination of its oligomeric structure. (A) PrrC-D222E-His6 was purified by high-speed centrifugation (S-30), immobilized
cobalt affinity-chromatography (IMAC) and Superdex-200 gel filtration (GF) as detailed in Materials and Methods and Table 1. Aliquots of the indicated
fractions were separated by SDS–PAGE and silver stained. (B) Superdex-200-elution profile of PrrC protein and ACNase activity. The TALON fraction of PrrC
was fractionated on a Superdex-200 column. ACNase activity and PrrC protein were detected in the eluted fractions as described in Materials and Methods. The
top inset shows the profile of SeeBlue stained PrrC protein, the lower inset the profile of the ACNase cleavage product of tRNA
Lys kDa—native protein size
markers. (C) GA-crosslinking profile of PrrC. The post-TALON fraction of PrrC was subjected to glutaraldehyde crosslinking. Aliquots taken at the indicated
times were separated by 5–13% gradient SDS–PAGE and visualized by staining, as detailed in Materials and Methods. kDa—protein size markers. PrrC2, 3 & 4
indicate putative PrrC dimer, trimer and tetramer forms, respectively.
Figure 3. TMAO stabilizes ACNase activity. (A) PrrC-D222E aliquots were
pre-incubated at the indicated temperatures for 30 min without or with 2 M
TMAO. ACNase activity was assayed then for 20 min at 10 C with 1 M
TMAO. (B) Inhibition of ACNase activity as a function of pre-incubation
temperature and TMAO level. (C) Tm of ACNase inactivation versus TMAO
level.
Table 1. PrrC-core ACNase purification
Purification Yield Specific
activity
(U/mg)
ACNase
(units
a)
Protein
(mg)
Step
1 100 800 16000 20 S-30
39 59 32 9500 0.3 TALON
41 37 33 6000 0.18 Superdex-200
a One ACNase unit is defined as 1 fmol tRNA
Lys cleaved per min at 10 C
under standard assay conditions (Materials and Methods).
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PrrC’s interaction with nucleotides affecting ACNase
activation was investigated by UV-crosslinking. GTP,
ATP and dTTP yielded each a conjugate that coincided in
SDS–PAGE with monomeric PrrC (Figure 5A). Such pro-
ducts were absent from or severely decreased in the non-
irradiated controls (lanes 23–28). The conjugates formed
with GTP or with ATP featured sigmoidal dose-response
Figure 5. UV-crosslinking nucleotides to PrrC. (A) PrrC was incubated with the indicated concentrations of radio-labeled GTP (lanes 1–7, 0.1, 0.2, 0.4, 0.6, 0.8,
1.0 and 1.5 mM, respectively), ATP (lanes 8–14, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0 and 1.5 mM, respectively) or dTTP (lanes 15–22, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5 and
2.0 mM, respectively) and UV-irradiated. The controls with and without radiation contained 0.5 mM GTP (lanes 23 and 24), 0.5 mM ATP (lanes 25 and 26) or
0.2 mM dTTP (lanes 27 and 28). The samples were separated by 10% SDS–PAGE, transferred to a nitrocellulose membrane, autoradiographed and
immunoblotted (Materials and Methods). (B) Effect of heat inactivation of ACNase on PrrC’s ability to UV-crosslink nucleotides and oligomeric structure.
Untreated PrrC or heat inactivated aliquots (2 min at 40 C) were assayed for ACNase activity (lanes 1 and 2), glutaraldehyde protein–protein crosslinking
(lanes 3–8) and UV-crosslinking the indicated nucleotides (lanes 9 and 10). (C) The indicated PrrC alleles were assayed for ability to UV-crosslink GTP
(lanes 1–6), ATP (lanes 7–12 ) or dTTP (lanes 13–18). The asterisk in the K46N*, K168N*, K171N* and H251N* labels indicate that these mutations were
introduced over the D222E background.
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tively). In contrast, the dTTP conjugate peaked at  0.2 mM
and declined above this level (lanes 15–22). This was unex-
pected since dTTP stabilizes core ACNase in a sigmoidal
dose-response pattern and its protective effect does not
level off even at 10 mM (18).
Inactivating ACNase by heating it for 2 min at 40 C
(Figure 5B, lanes 1 and 2) did not signiﬁcantly affect the oli-
gomeric organization (lanes 3–8) or ability to UV-crosslink
GTP or ATP, but abolished the UV-crosslinking to dTTP
(lanes 9 and 10).
Next we investigated the effects of NTPase motif muta-
tions introduced over the D222E background on the ability
of the three nucleotides to UV-crosslink PrrC. Mutating
K46 (Walker A), K171 (ABC signature) or H251 [corre-
sponding to the linchpin His of ABC-transporter ATPases,
Ref. (37)] had no apparent effect on the interactions of
PrrC with GTP (Figure 5C, lanes 3–5) or ATP (lanes 9–11)
but nearly abolished the interaction with dTTP (lanes 15–
17). However, mutating the conserved K168 found immedi-
ately upstream to the ABC signature motif severely inhibited
the UV-crosslinking of all three nucleotides (lanes 6, 12 and
18). All the double mutants investigated lacked ACNase
activity but were soluble and retained the typical oligomeric
structure (data not shown). The single D222E and D222N
mutants had similar ACNase activities and protein levels
(data not shown) and interacted similarly with each of the
three nucleotides (lanes 1, 2, 7, 8, 13 and 14).
Mutagenesis of potentially functional
C-domain residues
A catalytic ACNase site was looked for by mutating con-
served and potentially functional C-domain residues using
the conserved N-domain His
251 and less conserved C-domain
residues as controls. The mutations were introduced over
the wild-type background and their effects on the in vivo
core ACNase activity and level of PrrC protein determined.
Replacing the conserved Arg
320 by Ala or Gln reduced
ACNase activity below detection and increased the protein
yield 20- to 40-fold over wild-type (Figure 6, lanes 1–3).
The isofunctional R320K mutant retained trace activity
detected in some experiments (lanes 4, 10–12). In contrast,
Lys
325 that is present in 18/20 PrrC homologs (Figure 8)
seemed nonessential. Replacing it with Asn (Figure 6, lane 5)
or Ala (data not shown) had no effect on the activity and the
K325R mutation even stimulated it 2- to 3-fold. The latter
mutation reduced the PrrC protein level considerably
(compare lanes 1 and 6), possibly due to stronger inhibition
of translation. Replacing the conserved Glu324 (Figures 1
and 8) by Gln or Ala reduced the activity below detection
and enhanced the protein level (Figure 6, lanes 7 and 8)
but the isofunctional E324D mutation was less inhibitory
(lane 9). The non-conserved Asp
341 and Glu
371 could be
replaced without apparent loss of activity (data not shown).
Each of the three His
356 missense mutants investigated lacked
detectable ACNase activity whereas His
315 or His
251 mutants
featured over 20% the wild-type extent of cleavage. Mutating
His
295 had virtually no effect (Figure 6, lanes 13–18
and 20–22). Finally, replacing Tyr294 with Phe (Figure 6,
lanes 23–25) or Ser (data not shown) inactivated ACNase.
Tyr
294 was also probed because equivalents of this residue
exist in a large subset of the known PrrC proteins and the
remaining homologs contain His instead (Figure 8). More-
over, a Tyr residue could partake in the active site of an
archaeal tRNA splicing endonuclease (38).
Chemical rescue of suspected ACNase site mutants
The possible contributions of Arg
320, Glu
324, His
356 and
Tyr
294 to ACNase catalysis were further investigated by
attempted chemical rescue of their respective to-alanine or
to-serine mutants. In this approach a missing functional
side chain is substituted by a corresponding small molecule.
Partial restoration of the activity suggests that the mutant
retained the functional conformation and failed to act because
it lacked the critical side chain (39). As shown, guanidine
activated R320A (Figure 7A, lanes 1–6) but not E324A
(lanes 7–12) and ammonium acetate rescued E324A
(Figure 7B, lanes 13–18) but not R320A (lanes 19–24).
Sodium and ammonium acetate acted similarly (data not
shown), indicating that the rescuing agent was acetate.
However, H356A was not rescued by imidazole or its 2- or
4-methyl derivatives. Y294S was not rescued by phenol, imi-
dazole or acetate (data not shown). The rescue of Y294 was
attempted also with the latter two agents due to replacement
of Tyr
294 by His in some PrrC homologs and because the
Y142S mutant of porcine isocitrate dehydrogenase is rescued
by acetate (40).
DISCUSSION
Functional segregation of PrrC’s nucleotide
binding sites (NBS)
The glutaraldehyde crosslinking pattern of PrrC (Figure 4C)
resembles those of known dimer of dimers proteins, including
an ABC-transporter ATPase (33–36). Therefore, PrrC could
be similarly organized. However, this assumption remains
to be tested by more accurate size determinations and using
further stabilized forms of PrrC amenable to such analyses.
NBS arise in ABC-transporter ATPases by coalescence of
a Walker A motif of one subunit and ABC signature motif
Figure 6. In vivo ACNase activity and protein level of PrrC mutants. The
indicated PrrC mutants were compared to the wild-type allele in vivo ACNase
activity by radiolabeling the resultant 50-OH cleavage termini and for PrrC
protein level by western blotting as detailed in Materials and Methods.
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dimer of dimers, PrrC could contain four such NBS. How-
ever, these NBS could segregate into distinct subtypes speci-
ﬁc for GTP or dTTP, as indicated by the following facts.
First, the dose-response patterns the two nucleotides featured
in their UV-crosslinking to PrrC (Figure 5A) conﬁrmed the
vastly higher afﬁnity of dTTP for the protein, previously
inferred from the patterns of core ACNase protection by
dTTP and the GTP requirement in ACNase activation (18).
Second, GTP featured in the UV-crosslinking to PrrC the
anticipated sigmoidal-like dose-response whereas dTTP
yielded an unexpected optimum pattern (Figure 5A). Third,
changes in PrrC that entailed loss of ACNase activity without
disruption of the oligomeric structure of the protein, induced
by mild heating (Figure 5B) or mutating conserved NTPase
positions (Figure 5C), also abolished the UV-crosslinking
of PrrC to dTTP but not to GTP (Figure 5B). Fourth, GTP
and dTTP have been shown to cooperate in ACNase activa-
tion but only GTP seemed to be hydrolyzed in the process
(18). Taken together, these facts reinforce the notion that
PrrC contains a subset of low-afﬁnity, catalytic NBS speciﬁc
for GTP and a high-afﬁnity subset speciﬁc for dTTP. Since
both types are likely determined by the same NTPase motifs,
their distinguishing features could be acquired by asymmetric
subunit packing.
As mentioned, dTTP UV-crosslinked PrrC optimally at a
sub-mM level but poorly at higher levels where it effectively
protected the core ACNase activity (18). This discrepancy
may be reconciled by suggesting that during the cooperative
binding of dTTP to PrrC the protein undergoes a structural
change that shifts the photoreactive amino acid away from
the nucleotide base. The sensitivity of the PrrC-dTTP interac-
tion to modest changes in PrrC’s structure was also indicated
by the observations that mild heat treatment (Figure 5B)
or certain NTPase mutations (Figure 5C) abolished the UV-
crosslinking of PrrC to dTTP but not to GTP.
The similar dose-response patterns GTP exhibited in UV-
crosslinking PrrC (Figure 5A) or ACNase activation (18) sug-
gest that PrrC harbors the activating GTPase, although such
an activity remains to be demonstrated. It is noteworthy
that Asp222 of PrrC’s Walker B motif could be important
for hydrolysis of the bound nucleotide as in well-
characterized ATPases (42). Thus, the Asp
222 mutants used
here could be devoid of the anticipated GTPase activity.
GTP and ATP were similarly UV-crosslinked to PrrC
(Figure 5A). Therefore, they could exert their opposing
effects in ACNase activation by competing over the same
low-afﬁnity NBS. Presumably, ATP binding to PrrC within
the ACNase holoenzyme safeguards the latent state and
replacing it with GTP could alleviate this inhibition.
Is dTTP an obligatory co-activator of ACNase?
Latent ACNase can be activated in vitro without Stp by add-
ing dTTP, albeit, at levels far higher than needed to protect
core ACNase (18) or UV-crosslink PrrC (Figure 5A). This
alternative mode of activation could be taken to indicate
that ACNase is mobilized also in cellular stress situations
other than T4 infection. Alternatively, dTTP is an obligatory
co-activator of ACNase rendered more accessible to PrrC
within the latent holoenzyme by the T4-encoded peptide.
According to the latter interpretation, the excessive amount
of dTTP that enabled activating ACNase in the absence of
Stp helped bypass the requirement for Stp. Likewise, the
small amounts of dTTP in the cell-free extract sufﬁced for
activating ACNase when Stp was present. Further credence
to the notion that dTTP is an obligatory co-activator and
ACNase is mobilized speciﬁcally during phage T4 infection
is lent by (i) the increase in the cellular level of dTTP before
the onset of T4 DNA replication and ACNase activation
(18,43) and (ii) the sporadic distribution of PrrC among
bacteria (Figure 1), indicative of a niche-function rather
than participation in a general stress response.
The ACNase site
The in vivo ACNase assay allowed us to detect  10
2-fold
reduction in the extent of tRNA cleavage products considered
here an indirect measure of the reaction rate. However, the
Figure 7. Chemical rescue of PrrC mutants. (A) The indicated PrrC alleles were assayed for ACNase activity in the presence of the indicated concentrations of
guanidine-HCl or (B) ammonium acetate. (C) Relative ACNase activities versus guanidine-HCl or (D) ammonium acetate concentration.
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3–4-fold rate reduction
expected from loss of a catalytic RNase group (44) because
the mutant proteins were more abundant than wild-type
PrrC (Figure 6). This consideration, taken with (i) the conser-
vation of Arg
320 and Glu
324, (ii) the null phenotypes of the
isosteric and alanine mutants of Arg
320 and Glu
324, (iii) the
leaky phenotypes of their isofunctional mutants (Figure 6)
and (iv) the chemical rescue data (Figure 7) strongly suggest
that Arg
320 and Glu
324 partake in ACNase catalysis. Speciﬁ-
cally, the positively charged Arg
320 could be the TSP stabili-
zer and Glu
324 the general base catalyst, by analogy with
classical RNases that delegate this function to Glu or His.
In contrast, the general acid catalyst is always a His residue
(28). His
356 seems the best candidate for the latter function
by default, due to its conservation and, importantly, the
failure of its missense mutants to elicit detectable ACNase
activity (Figure 6). In contrast, mutating other conserved
His residues had milder or no effect on ACNase activity.
Nonetheless, the failure to chemically rescue the H356A
mutant calls for further examination of the His
356 assignment.
Tyr
294 also seems a less likely candidate for a catalytic role
despite the null phenotypes of its mutants. Namely, this resi-
due is only partially conserved among the PrrC homologs.
Moreover, as indicated below, it could partake in tRNALys
binding. The putative Arg
320-Glu
324-His
356 ACNase triad
resembles in composition that of RNase T1 (26) and,
hence, could assume a similar arrangement about the sub-
strate’s scissile phosphodiester linkage. However, in view
of the oligomeric structure of PrrC the possibility that the
ACNase site is shared by interfacing subunits should also
be considered.
The PrrC restriction RNases
As mentioned, all known PrrC proteins feature the Arg
320-
Glu
324-His
356 triad (Figure 8). Therefore, they are also
expected to function all as RNases. Moreover, all of them
feature the N-proximal NTPase motifs (Figure 1) and are
genetically linked to EcoprrI homologs. Hence, they could
all function as second-strike restriction RNases, i.e. being
activated to counteract phage infection when the associated
DNA restriction nuclease is compromised by the phage, as
with the E.coli prototype (17). Another shared motif, rich
in acidic, hydrophobic and aromatic residues (‘PrrC box’,
residues 68–94 in Figure 1) is unique to the PrrC family.
Hence, it likely plays a speciﬁc role, e.g. interfacing EcoprrI
and/or communicating with the ACNase domain.
Residues Asp
287 and Ser
288 of E.coli PrrC have been impli-
cated in tRNA
Lys recognition (23–25). Preliminary peptide
mimicry data suggest that a contiguous stretch to which
these residues belong interacts with the tRNA
Lys anticodon
(D. Klaiman, S. Blanga, M. Amitsur and G. Kaufmann;
unpublished data). This stretch includes the essential aromatic
residues Phe
292 (23) and Tyr
294 (Figure 6) and coincides with
a consensus sequence shared by a subset of PrrC homologs
more closely related to the E.coli prototype than the other
homologs (Figure 8). In the remaining homologs the corre-
sponding region differs considerably in sequence. Therefore,
these homologs likely target one or more different RNA
structures.
Clearly, functional characterization of the PrrC homologs
will be required to examine these various expectations,
which rest mainly on DNA sequence data.
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